Patent assignee · US · COMPANY

Riboscience LLC

12Patents
12Active
12Granted
48Portfolio score

Filing activity: Dec 17, 2012 → May 4, 2020

Most-cited patents

PatentTitleAreaCited byStatus
US9108999B2 2′, 4′-difluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication Chemistry; Metallurgy 7 Active
US9370569B2 4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication Chemistry; Metallurgy 4 Active
US10092649B2 4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication Chemistry; Metallurgy 3 Active
US9895442B2 4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication Chemistry; Metallurgy 2 Active
US9249176B2 4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication Chemistry; Metallurgy 1 Active
US10682369B2 4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication Chemistry; Metallurgy 0 Active
US11351186B2 4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication Chemistry; Metallurgy 0 Active
US9694028B2 4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication Chemistry; Metallurgy 0 Active
US10358458B2 4′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication Chemistry; Metallurgy 0 Active
US10953030B2 4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication Human Necessities 0 Active
US9708357B2 4′-azido, 3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication Chemistry; Metallurgy 0 Active
US12029744B2 Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.